Feb 28, 2022 8:00am EST NeuBase Therapeutics to Present New Preclinical Data for Myotonic Dystrophy Type 1 Program at the 2022 MDA Clinical & Scientific Conference
Feb 10, 2022 7:00pm EST NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2022
Dec 23, 2021 4:01pm EST NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021
Sep 28, 2021 4:05pm EDT NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference
Sep 15, 2021 4:05pm EDT NeuBase to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 14, 2021 8:00am EDT NeuBase Therapeutics Appoints Anthony Rossomando, Ph.D. as Chief Technology Officer